Everly Bio is transforming fertility care by applying advanced Molecular Biology and Machine Learning to significantly improve IVF success rates.
With a groundbreaking decision-support platform, Everly Bio offers personalized, data-driven solutions that make treatments more accessible and effective in the rising global market of IVF.
CEO: Michal Gilon Ohev-Zion, PhD